SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-15-007645
Filing Date
2015-08-31
Accepted
2015-08-31 16:29:17
Documents
13
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q aimt-10q_20150630.htm 10-Q 1833276
2 EX-10.2 aimt-ex102_366.htm EX-10.2 126545
3 EX-31.1 aimt-ex311_42.htm EX-31.1 11752
4 EX-31.2 aimt-ex312_43.htm EX-31.2 11782
5 EX-32.1 aimt-ex321_44.htm EX-32.1 8470
6 GRAPHIC g2015083118555619145.jpg GRAPHIC 37646
7 GRAPHIC g2015083118555705046.jpg GRAPHIC 67031
  Complete submission text file 0001564590-15-007645.txt   5872290

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT aimt-20150630.xml EX-101.INS 1086819
9 XBRL TAXONOMY EXTENSION SCHEMA aimt-20150630.xsd EX-101.SCH 35375
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aimt-20150630_cal.xml EX-101.CAL 29391
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aimt-20150630_def.xml EX-101.DEF 135529
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE aimt-20150630_lab.xml EX-101.LAB 278380
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aimt-20150630_pre.xml EX-101.PRE 242988
Mailing Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884
Business Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884 (650) 614-5220
Aimmune Therapeutics, Inc. (Filer) CIK: 0001631650 (see all company filings)

IRS No.: 452748244 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37519 | Film No.: 151085251
SIC: 2834 Pharmaceutical Preparations